>> View All Results for ""
Enter multiple symbols separated by commas
London quotes now available
Not even $3 billion could convince Snapchat's founders to go work for Facebook's Mark Zuckerberg, but it was a better week for Amazon and Apple.
CNBC's Jane Wells looks at Promescent, a new drug for men that treats premature ejaculation.
The FMHR traders reveal their final trades of the hour.
CNBC's Bob Pisani and Art Cashin, of UBS, discuss rumors of when the Fed may taper, and whether the markets are headed towards a "Santa Claus rally."